• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Stocks That Hit 52-Week Lows On Friday

    2/10/23 1:22:43 PM ET
    $ABEV
    $ALLR
    $ASTI
    $AWIN
    Beverages (Production/Distribution)
    Consumer Staples
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $ABEV alert in real time by email

     

    During Friday, 48 stocks hit new 52-week lows.

    Key Facts About Today's 52-Week Lows:

    • The largest company by market cap to set a new 52-week low was Ambev (NYSE:ABEV).
    • Reshape Lifesciences (NASDAQ:RSLS) was the smallest company when considering market cap to set a new 52-week low.
    • Soligenix (NASDAQ:SNGX) shares traded down 1193.45% to reach its 52-week low, making it the biggest loser.
    • Vertical Aerospace (NYSE:EVTL) shares bounced back the most, actually rising 0.0% after hiting a new 52-week low.

    The stocks that set new 52-week lows on Friday:

    • Ambev (NYSE:ABEV) stock achieved a new 52-week low on Friday morning, hitting $2.41 and moving down 1.43%.
    • Bank Bradesco (NYSE:BBD) stock hit a yearly low of $2.43. The stock was down 6.98% for the day.
    • Sirius XM Holdings (NASDAQ:SIRI) shares were down 0.42% for the day, having made a 52-week low of $4.72.
    • Hanesbrands (NYSE:HBI) shares set a new 52-week low of $5.60. The stock traded down 0.79%.
    • Sterling Check (NASDAQ:STER) shares set a new yearly low of $11.92 this morning. The stock was down 11.46% on the session.
    • Cronos Group (NASDAQ:CRON) shares made a new 52-week low of $2.26 on Friday. The stock was down 1.72% for the day.
    • Mercer Intl (NASDAQ:MERC) shares fell to $10.55 on Friday, setting a new 52-week low with a shift of down 10.52%.
    • Azul (NYSE:AZUL) stock hit $5.19 on Friday morning, setting a new 52-week low for a change of down 4.59%.
    • Vertical Aerospace (NYSE:EVTL) stock hit a yearly low of $1.94. The stock was 0.0% (flat) for the day.
    • Bridger Aerospace Gr (NASDAQ:BAER) stock hit a new 52-week low of $3.77. The stock was down 2.18% on the session.
    • Guaranty Bancshares (NASDAQ:GNTY) shares hit a yearly low of $31.10. The stock was up 0.09% on the session.
    • Hyzon Motors (NASDAQ:HYZN) shares reached a new 52-week low of $1.25 on Friday morning, moving down 23.94%.
    • Tupperware Brands (NYSE:TUP) shares reached a new 52-week low of $3.72 on Friday morning, moving down 1.28%.
    • Cerberus Cyber Sentinel (NASDAQ:CISO) shares fell to $1.10 on Friday, setting a new 52-week low with a shift of down 6.38%.
    • GreenLight Biosciences (NASDAQ:GRNA) stock hit $0.86 on Friday morning, setting a new 52-week low for a change of down 3.92%.
    • AERWINS Technologies (NASDAQ:AWIN) stock hit a yearly low of $2.04. The stock was down 6.11% for the day.
    • Clough Global Equity (AMEX:GLQ) shares hit a yearly low of $6.14. The stock was up 0.33% on the session.
    • Vintage Wine Estates (NASDAQ:VWE) stock achieved a new 52-week low on Friday morning, hitting $1.85 and moving down 5.48%.
    • Heliogen (NYSE:HLGN) stock set a new 52-week low of $0.38 on Friday, moving down 8.33%.
    • NeoVolta (NASDAQ:NEOV) shares set a new yearly low of $1.96 this morning. The stock was down 7.11% on the session.
    • Taysha Gene Therapies (NASDAQ:TSHA) stock broke to a new 52-week low of $1.02 on Friday. Shares of the company traded down 2.38%.
    • P3 Health Partners (NASDAQ:PIII) stock achieved a new 52-week low on Friday morning, hitting $1.05 and moving down 4.0%.
    • 9F (NASDAQ:JFU) stock dropped to a yearly low on Friday of $3.13. Shares traded down 8.92%.
    • Ascent Solar Technologies (NASDAQ:ASTI) shares moved down 2.09% on Friday to hit a new 52-week low of $0.80, drifting down 2.09%.
    • MGO Global (NASDAQ:MGOL) shares set a new 52-week low of $1.79. The stock traded down 9.05%.
    • Cadrenal Therapeutics (NASDAQ:CVKD) stock broke to a new 52-week low of $1.86 on Friday. Shares of the company traded down 0.1%.
    • CN Energy Group (NASDAQ:CNEY) shares set a new yearly low of $0.41 this morning. The stock was down 6.33% on the session.
    • Can Fite Biofarma (AMEX:CANF) shares set a new yearly low of $3.35 this morning. The stock was down 4.23% on the session.
    • WiSA Technologies (NASDAQ:WISA) stock achieved a new 52-week low on Friday morning, hitting $5.99 and moving down 4.31%.
    • Tenax Therapeutics (NASDAQ:TENX) shares fell to $1.03 on Friday, setting a new 52-week low with a shift of down 2.73%.
    • Panbela Therapeutics (NASDAQ:PBLA) shares reached a new 52-week low of $1.23 on Friday morning, moving down 7.95%.
    • OceanPal (NASDAQ:OP) stock hit a new 52-week low of $0.62. The stock was down 10.98% on the session.
    • OpGen (NASDAQ:OPGN) stock hit a new 52-week low of $1.45. The stock was down 4.97% on the session.
    • Allarity Therapeutics (NASDAQ:ALLR) shares reached a new 52-week low of $0.18 on Friday morning, moving down 1.76%.
    • Reshape Lifesciences (NASDAQ:RSLS) shares hit a yearly low of $5.10. The stock was down 5.06% on the session.

    Be sure to monitor Benzinga for the news traders need! And for even more up-to-date info on 52-week lows and highs, check out Benzinga Pro. This cutting-edge market research platform alerts traders of which stocks are trading near their 52-week highs and lows each morning - and delivers lots of other actionable data. Learn more here.

    Get the next $ABEV alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ABEV
    $ALLR
    $ASTI
    $AWIN

    CompanyDatePrice TargetRatingAnalyst
    Banco Bradesco Sa
    $BBD
    10/14/2025Sell → Neutral
    Goldman
    NeoVolta Inc.
    $NEOV
    10/1/2025Buy → Hold
    Maxim Group
    Tenax Therapeutics Inc.
    $TENX
    9/8/2025$20.00Overweight
    Piper Sandler
    P3 Health Partners Inc.
    $PIII
    8/28/2025$20.00Buy
    Lake Street
    Vertical Aerospace Ltd.
    $EVTL
    8/22/2025$8.00Overweight
    Cantor Fitzgerald
    Ambev S.A.
    $ABEV
    8/1/2025Buy → Hold
    HSBC Securities
    Allarity Therapeutics Inc.
    $ALLR
    7/28/2025$9.00Buy
    Ascendiant Capital Markets
    Vertical Aerospace Ltd.
    $EVTL
    7/17/2025$9.00Buy
    Needham
    More analyst ratings

    $ABEV
    $ALLR
    $ASTI
    $AWIN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    CEO and Chairman Pham Quang X sold $50,706 worth of shares (3,600 units at $14.09), decreasing direct ownership by 2% to 198,533 units (SEC Form 4)

    4 - Cadrenal Therapeutics, Inc. (0001937993) (Issuer)

    10/14/25 4:05:13 PM ET
    $CVKD
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Chief Financial Officer Szot Matthew K sold $49,011 worth of shares (3,493 units at $14.03), decreasing direct ownership by 21% to 13,533 units (SEC Form 4)

    4 - Cadrenal Therapeutics, Inc. (0001937993) (Issuer)

    10/14/25 4:05:15 PM ET
    $CVKD
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Large owner Willson Brent sold $5,000 worth of shares (500,000 units at $0.01) (SEC Form 4)

    4 - NeoVolta Inc. (0001748137) (Issuer)

    10/10/25 6:32:29 PM ET
    $NEOV
    Industrial Machinery/Components
    Miscellaneous

    $ABEV
    $ALLR
    $ASTI
    $AWIN
    SEC Filings

    View All

    SEC Form 8-K filed by Taysha Gene Therapies Inc.

    8-K - Taysha Gene Therapies, Inc. (0001806310) (Filer)

    10/16/25 4:10:20 PM ET
    $TSHA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form 144 filed by Cadrenal Therapeutics Inc.

    144 - Cadrenal Therapeutics, Inc. (0001937993) (Subject)

    10/14/25 9:44:37 AM ET
    $CVKD
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 144 filed by Cadrenal Therapeutics Inc.

    144 - Cadrenal Therapeutics, Inc. (0001937993) (Subject)

    10/14/25 7:41:37 AM ET
    $CVKD
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ABEV
    $ALLR
    $ASTI
    $AWIN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    $ABEV
    $ALLR
    $ASTI
    $AWIN
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Banco Bradesco upgraded by Goldman

    Goldman upgraded Banco Bradesco from Sell to Neutral

    10/14/25 8:35:27 AM ET
    $BBD
    Major Banks
    Finance

    NeoVolta downgraded by Maxim Group

    Maxim Group downgraded NeoVolta from Buy to Hold

    10/1/25 8:19:55 AM ET
    $NEOV
    Industrial Machinery/Components
    Miscellaneous

    Piper Sandler initiated coverage on Tenax Therapeutics with a new price target

    Piper Sandler initiated coverage of Tenax Therapeutics with a rating of Overweight and set a new price target of $20.00

    9/8/25 8:59:21 AM ET
    $TENX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    CHAIRMAN, CEO AND PRESIDENT Schaber Christopher J bought $20,000 worth of shares (15,132 units at $1.32), increasing direct ownership by 3,993% to 15,511 units (SEC Form 4)

    4 - SOLIGENIX, INC. (0000812796) (Issuer)

    10/3/25 1:18:09 PM ET
    $SNGX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Welty Linda J bought $30,866 worth of shares (10,000 units at $3.09), increasing direct ownership by 38% to 36,290 units (SEC Form 4)

    4 - MERCER INTERNATIONAL INC. (0001333274) (Issuer)

    8/19/25 12:23:28 PM ET
    $MERC
    Paper
    Basic Materials

    Director Laberge Alice bought $5,957 worth of shares (2,000 units at $2.98), increasing direct ownership by 20% to 12,065 units (SEC Form 4)

    4 - MERCER INTERNATIONAL INC. (0001333274) (Issuer)

    8/8/25 5:50:55 PM ET
    $MERC
    Paper
    Basic Materials

    $ABEV
    $ALLR
    $ASTI
    $AWIN
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Taysha Gene Therapies Regains Full Rights to Lead TSHA-102 Program in Clinical Evaluation for the Treatment of Rett Syndrome

    The 2022 Option Agreement between Astellas and Taysha has expired Regaining full rights to TSHA-102 Rett syndrome program enables Taysha to focus on driving its long-term value with full strategic flexibility and optionality TSHA-102 has demonstrated compelling Part A REVEAL Phase 1/2 safety and efficacy data, received FDA Breakthrough Therapy designation and is advancing with a clear path to potential registration Dosing of the first patient in the REVEAL pivotal trial is scheduled this quarter DALLAS, Oct. 16, 2025 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (NASDAQ:TSHA) (Taysha or the Company), a clinical-stage biotechnology company focused on advancing adeno-associated virus (

    10/16/25 4:01:00 PM ET
    $TSHA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    CISO Global CEO David Jemmett to Present at LD Micro Main Event XIX

     Scottsdale, AZ, Oct. 15, 2025 (GLOBE NEWSWIRE) -- CISO Global (NASDAQ:CISO), a leading provider of AI-powered cybersecurity software and compliance services, today announced that its Chief Executive Officer, David Jemmett, will be presenting at the LD Micro Main Event XIX on both October 19 and October 21, 2025, at the Hotel Del Coronado in San Diego, CA. On the 19th, Mr. Jemmett will participate in a Fireside Chat titled: "Tales from the Microcap Twilight Zone – Discussing Trades that Have No Explanation." The session will feature a conversation with Todd Feinstein, Founder and Partner at Feinstein Law, who brings a distinctive perspective from his career as a broker, trader, compliance

    10/15/25 8:30:00 AM ET
    $CISO
    Professional Services
    Consumer Discretionary

    NeoVolta Closes Neubau Energy Asset Purchase to Launch neuClick™ Modular Battery Platform

    SAN DIEGO, Oct. 15, 2025 (GLOBE NEWSWIRE) -- NeoVolta Inc. (NASDAQ:NEOV) closed its previously announced purchase of strategic assets of Neubau Energy, a developer of next-generation modular battery technology. [Link] "Closing our purchase of Neubau's assets and next-gen battery platform is a significant milestone, expanding NeoVolta's branded product suite and enabling new revenue streams," said Ardes Johnson, Chief Executive Officer of NeoVolta. "Key executive hires from Neubau have already been added to our team. In addition, the transaction immediately increases our market reach; enhances our gross margins; increases our mix of domestic content, thus mitigating the expected impact of

    10/15/25 8:30:00 AM ET
    $NEOV
    Industrial Machinery/Components
    Miscellaneous

    $ABEV
    $ALLR
    $ASTI
    $AWIN
    Financials

    Live finance-specific insights

    View All

    SiriusXM to Report Third Quarter 2025 Operating and Financial Results

    NEW YORK, Oct. 1, 2025 /PRNewswire/ -- SiriusXM (NASDAQ:SIRI) will release its third quarter 2025 operating and financial results on Thursday, October 30, and will hold an investor call that same day at 8:00 a.m. ET. A live webcast of the call will be available on the SiriusXM Investor Relations website at https://investor.siriusxm.com. To participate by telephone, please dial 1.877.407.4019 (Toll-free) or 1.201.689.8337 (Local) 10 minutes prior to the start of the call and ask to be connected to the SiriusXM conference call. About Sirius XM Holdings Inc.SiriusXM is the leadin

    10/1/25 4:30:00 PM ET
    $SIRI
    Broadcasting
    Consumer Discretionary

    Guaranty Bancshares, Inc. Declares Special Cash Dividend and Announces Approval of Merger Agreement

    Guaranty Bancshares, Inc. (NYSE:GNTY) (the "Company"), the parent company of Guaranty Bank & Trust, N.A. (the "Bank"), today announced that its Board of Directors has declared a special cash dividend on its common stock in the amount of $2.30 per share of common stock (the "Special Dividend"). The Special Dividend will be paid on September 23, 2025, to shareholders of record as of the close of business on September 19, 2025. The Special Dividend is being paid in connection with the previously announced Plan and Agreement of Merger, dated as of June 24, 2025 (the "Merger Agreement"), by and among the Company, the Bank, Glacier Bancorp, Inc. ("GBCI") and its wholly owned subsidiary, Glacier B

    9/17/25 4:30:00 PM ET
    $GNTY
    Major Banks
    Finance

    Cadrenal Therapeutics Enhances Anticoagulation Pipeline Through Acquisition of eXIthera's Portfolio of Factor XIa Inhibitors

    Acquisition significantly enhances the Company's pipeline by adding novel assets in acute and chronic anticoagulation settingsCompany is strategically poised to deliver differentiated therapeutics across the spectrum of cardiovascular thrombotic risk PONTE VEDRA, Fla., Sept. 15, 2025 (GLOBE NEWSWIRE) -- Cadrenal Therapeutics, Inc. (NASDAQ:CVKD), a biopharmaceutical company developing transformative therapeutics to overcome the gaps in anticoagulation therapy, today announced the acquisition of the assets of eXIthera Pharmaceuticals ("eXIthera"), including its proprietary portfolio of investigational intravenous (IV) and oral Factor XIa inhibitors. The acquisition significantly enhances Ca

    9/15/25 8:00:00 AM ET
    $CVKD
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ABEV
    $ALLR
    $ASTI
    $AWIN
    Leadership Updates

    Live Leadership Updates

    View All

    NeoVolta Enters Into Asset Purchase Agreement for Neubau Energy's Next-Generation Battery Platform; Expects Transaction to Be Immediately Accretive to Revenues and Gross Margins

    SAN DIEGO, Oct. 07, 2025 (GLOBE NEWSWIRE) -- NeoVolta Inc. (NASDAQ:NEOV) entered into on October 1, 2025 an asset purchase agreement for the purchase of strategic assets of Neubau Energy pursuant to its letter of intent announced on September 10, 2025 [link]. The acquisition is expected to close by October 15, 2025. Concurrently, NeoVolta hired Neubau executives, naming Amany Ibrahim as chief operating officer and Thomas Enzendorfer as chief technology officer. Michael Mendik, the company's previous chief operating officer, will continue with the company and serve as its chief product officer. "Merging Neubau's talent and next-gen battery manufacturing platform is a significant milestone

    10/7/25 7:05:00 AM ET
    $NEOV
    Industrial Machinery/Components
    Miscellaneous

    CISO Global Strengthens Balance Sheet, Positions for Growth and Strategic Opportunities

    Scottsdale, AZ, Oct. 01, 2025 (GLOBE NEWSWIRE) -- CISO Global (NASDAQ:CISO) a leading provider of AI-powered cybersecurity software and compliance services, today announced it is well-positioned to accelerate sales growth and pursue strategic opportunities following significant steps to strengthen its balance sheet. The Company recently exchanged the last remaining investor debt into Preferred A shares, with no associated warrants. This transaction eliminated more than $9 million in debt, moving it to equity now held by two long-term supporters of CISO Global. Earlier this week, CISO Global announced a financing agreement with B. Riley that provides up to $15 million in potential growth

    10/1/25 8:30:00 AM ET
    $CISO
    Professional Services
    Consumer Discretionary

    Soligenix Announces Appointment of Former White House Economic Adviser Tomas J. Philipson, PhD as Strategic Advisor

    Contributing Broad Business and Government Affairs Expertise and Network PRINCETON, N.J., Sept. 23, 2025 /PRNewswire/ -- Soligenix, Inc. (NASDAQ:SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today the appointment of Tomas J. Philipson, PhD as a Strategic Advisor. Dr. Philipson is considered an expert in United States (U.S.) economic policy, particularly health care policy, and frequently appears on major media outlets, including F

    9/23/25 7:30:00 AM ET
    $SNGX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ABEV
    $ALLR
    $ASTI
    $AWIN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Azul S.A.

    SC 13G - AZUL SA (0001432364) (Subject)

    12/6/24 4:26:59 PM ET
    $AZUL
    Air Freight/Delivery Services
    Consumer Discretionary

    Amendment: SEC Form SC 13D/A filed by OceanPal Inc.

    SC 13D/A - OceanPal Inc. (0001869467) (Subject)

    12/2/24 4:18:52 PM ET
    $OP
    Marine Transportation
    Consumer Discretionary

    Amendment: SEC Form SC 13D/A filed by OceanPal Inc.

    SC 13D/A - OceanPal Inc. (0001869467) (Subject)

    12/2/24 4:17:41 PM ET
    $OP
    Marine Transportation
    Consumer Discretionary